Medexus: Medexus Pharma Revenue and Profits Surge on Acquisitions

Following Monday's closing bell, Canadian specialty pharma company Medexus Pharmaceuticals (TSX-V:MDP)(OTCQB:PDDPF) released its results from operations for the quarter and fiscal year ended March 31, 2019 showing a dramatic improvement in the top and bottom lines compared to a year earlier. The books were catalyzed by the company formerly known as Pediapharm completing mergers with ...Continue reading "Medexus Pharma Revenue and Profits Surge on Acquisitions"The post Medexus Pharma Revenue and Profits Surge on Acquisitions appeared first on Wall Street PR.